Intermittent Explosive Disorder
📧 Sign up to get email alerts when something new happens for Intermittent Explosive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Inflammatory Challenge in Human Aggression. [Phase 2]
Phase 2 clinical trial update exploring inflammatory challenge in intermittent explosive disorder; currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Neural Correlates During Alcohol Intoxication [Phase 2]
A Phase 2 clinical trial at Ohio State University studying neural correlates during alcohol intoxication in individuals with Alcohol Use Dis…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Effect of Nitrous Oxide on Aggression. [Phase 2]
Phase 2 study evaluating nitrous oxide for aggression in Intermittent Explosive Disorder; recruitment is ongoing at Ohio State University.
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Pimavanserin and Aggression and Social Cognition. [Phase 2]
Phase 2 clinical trial evaluating Pimavanserin for aggression and social cognition in Intermittent Explosive Disorder; currently recruiting …
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: Psychotherapy for Intermittent Explosive Disorder [NA]
University of Chicago-sponsored psychotherapy trial for Intermittent Explosive Disorder has completed. The record indicates the study status…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder [Phase 2]
Phase 2 trial of AVP-786 for intermittent explosive disorder was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder [Phase 1, Phase 2]
Clinical trials evaluating SRX246 in adults with intermittent explosive disorder have completed (Phase 1/2) with posted results.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder [Phase 4]
A Phase 4 trial comparing Intuniv to placebo in children with Intermittent Explosive Disorder has completed. Results were posted in November…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone. [Phase 3]
A completed Phase 3 study assessing whether Risperidone causes any cognitive or motor effects in youths with several behavioral and developm…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order [Phase 4]
A Phase 4 trial evaluating the efficacy of a triptan to reduce hostility and aggression in convicts under psychiatric treatment orders was t…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder [Phase 2]
Phase 2 trial comparing fluoxetine vs divalproex for intermittent explosive disorder has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IED [Phase 2]
A Phase 2 pilot trial from the University of Chicago compared group- and individual-delivered anger management in individuals with Intermitt…